These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30041584)

  • 1. Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
    Rambaran KA; Seifert CF
    J Oncol Pharm Pract; 2019 Jun; 25(4):884-890. PubMed ID: 30041584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
    Copeland V; McLaughlin M; Trifilio S
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    Alexander S; Fisher BT; Gaur AH; Dvorak CC; Villa Luna D; Dang H; Chen L; Green M; Nieder ML; Fisher B; Bailey LC; Wiernikowski J; Sung L;
    JAMA; 2018 Sep; 320(10):995-1004. PubMed ID: 30208456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
    Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
    Choeyprasert W; Hongeng S; Anurathapan U; Pakakasama S
    Int J Hematol; 2017 Feb; 105(2):213-220. PubMed ID: 27771837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation].
    Fernandez Sojo J; Batlle Massana M; Morgades M; Vives Polo S; Quesada MD; Ribera Santasusana JM
    Med Clin (Barc); 2016 Jan; 146(1):16-9. PubMed ID: 26343154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
    Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.
    Hafez HA; Yousif D; Abbassi M; Elborai Y; Elhaddad A
    Clin Transplant; 2015 Dec; 29(12):1112-8. PubMed ID: 26363413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
    Satlin MJ; Chavda KD; Baker TM; Chen L; Shashkina E; Soave R; Small CB; Jacobs SE; Shore TB; van Besien K; Westblade LF; Schuetz AN; Fowler VG; Jenkins SG; Walsh TJ; Kreiswirth BN
    Clin Infect Dis; 2018 Nov; 67(11):1720-1728. PubMed ID: 29701766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
    Gardner JC; Courter JD; Dandoy CE; Davies SM; Teusink-Cross A
    Transplant Cell Ther; 2022 Mar; 28(3):167.e1-167.e5. PubMed ID: 34875405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
    Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
    Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
    Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
    Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Przybylski DJ; Reeves DJ
    Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.
    Clemmons AB; Gandhi AS; Albrecht B; Jacobson S; Pantin J
    J Oncol Pharm Pract; 2019 Mar; 25(2):326-332. PubMed ID: 29059026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levofloxacin prophylaxis in neutropenic patients].
    Carena AA; Jorge L; Bonvehí P; Temporiti E; Zárate MS; Herrera F
    Medicina (B Aires); 2016; 76(5):295-303. PubMed ID: 27723617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.